ASX - General. ASX - By Stock. IXC Price at posting: 23. . RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. 0. Created with Sketch. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. I think having this out we can discuss on the way. . Created with Sketch. A new thread to put trading comments / reasoning / opinions in. . , page-32. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. Given the quality of the posters on the IXC thread I am confident others will do the same. 30 is a good sign as well. Created with Sketch. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. 4KB OECCreated with Sketch. Orphan drug status. . Last updated 15. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. ASX - Day TradingI bought some today at 44. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. All IMO IXC Price at posting: 37. Join the HotCopper ASX share market forum today for free. In 2005, IIH cost the American health care. . 91%) As of 03:35PM EST. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. . Created with Sketch. Created with Sketch. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. Quarterly Activities/Appendix 4C Cash Flow Report. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Andrew Forrest , or his entities have been involved with IXC since inception. ASX - By Stock. Market . 50%. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. IXC below Example of that is NEUInvestor Presentation, page-3. ASX - General. Created with Sketch. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. AVALANCHE. Created with. ASX - By Stock. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Forums. . . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. It's essentially a cashed up shell company right now it. Ceasing to be a substantial holder. . Forums. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. British Columbia, Selkirk Mountains. ASX - By Stock. wonder if the GLP-1 agonist referred to in this media release. ASX - By Stock. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Proposed listing date: 4 JULY 2019#Created with Sketch. 31% more bullish than other Healthcare sector stocks. ASX - By Stock. 3. As thread states post your questions here and let’s start compiling a list. 05. Latest Posts. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. ASX - Short Term Trading. Top Smart Score Stocks. Also took placement stock @$1. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Fully funded. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. Latest Posts. ASX - By Stock. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Forums. Created with Sketch. . IXC Valuation Report MST. ASX - Day Trading. 1. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Created with Sketch. ASX - By Stock. ASX - By Stock. IXC (ASX) Ann: Trading Halt - HotCopper. Invex Receives Approval for Paediatric Plan from the EMA, page-2. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. 8M ! Add to my watchlist. , page-35. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. . Created with Sketch. ASX - By Stock. My understanding is that NEU went from around $1. Created with Sketch. Both approaches can work, but it is not wise to confuse the two. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC Price at posting: 79. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. , page-3. Appendix 4E and Annual Report, page-3. Backed by Twiggy. With a team of 68. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Lucky for you all IXC still sits at only 60 cents. ASX - By Stock. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. Latest Posts. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. . Created with Sketch. ASX - By Stock. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. ASX - Day Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. ASX - Day Tradingis invex releasing 2. 6% $DLM 50. Met primary endpoints for phase 2 trials. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). . here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Theres alot of breakdowns above that are yet to be backtested. , page-3. . . , page-3. Share Appreciate the commentary and post. ASX - General. Market . Market . ASX - By Stock. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - By Stock. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. 0% $ODM 35. Forums. IXC Price at posting:. . INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. . IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Initial FDA and EMA Advice on Presendin Development, page-3. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. , page-2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. I think having this out we can discuss on the way. Some people like to gamble on stocks, others invest. Created with Sketch. Latest Posts. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. 0. Created with Sketch. Cold Comfort Ice Cream Company, Victoria, British Columbia. . Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. ASX - By Stock. Forums. Join the HotCopper ASX share market forum today for free. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Created with Sketch. . . . . ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. . 30 Haven’t supported share price since then on market . ASX - Day Trading. ASX - By Stock. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 3¢. So your thesis is right on a long time time frame. Proposed Capital Return to Shareholders of $14. Market . Created with Sketch. IXC has alot of catching up to do. IXC Valuation Report MST. My. The announcement was certainly a setback but we're not dead in. Advertise. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Although, IXC is trading about 3-4x lower than what I expect it to be. ASX - By Stock. . Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. . ASX - General. ASX - By Stock. Advertise on HotCopper. ASX - By Stock. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Created with Sketch. ASX - By Stock. ASX - By Stock. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. IXC could also be worth $14 on a successful trial and licensing deal (or takeover). ASX - By Stock. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Forums. 1950. Created with Sketch. 30 Haven’t supported share price since then on market . At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. AX stock on Yahoo Finance. Created with Sketch. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Some people like to gamble on stocks, others invest. Market . 1956773. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Only took that large seller to sell, now liquidity has dried up and. . Appreciate your input Dr T. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. sentiment based on opinions from HotCopper and others. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Invex Granted Key European Patent for Exenatide, page-2. Created with Sketch. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). Invex Receives Approval for Paediatric Plan from the EMA, page-3. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. But lets not talk about NSB here, we are here to see progress with IXC. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . gov and there is lots of good information about the trial. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. , page-4. Been. Market . Charts. Last updated 10. Just another way to saying that we've got Patient 1 out of 240. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. I see it at perhaps $5 prior to readout. Notification of cessation of securities - IXC. . Trading HaltDCF Valuation: IXC Intrinsic Value of $6. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. ASX - Day TradingSomeone bought $500 stock today at 44 cents. About 90 percent of the U. 64440. ASX - General. ASX. Latest Posts. 0 Million. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Probably been disappointed like all of us Created with Sketch. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Created with Sketch. IXC needs to be proactive and release a statement. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. a shell trading below cash backing, ripe. ASX - Day TradingHere's a very good opportunity for people in Sydney. ASX - Day Trading. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Market open. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. 375,000. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Join the HotCopper ASX share market forum today for free. . A new thread to put trading comments / reasoning / opinions in. . ASX - Short Term Trading. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. . , page-5. Share Not unexpected. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. . ASX - Day Trading. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. , page-2. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Invex Therapeutics Lists on ASX, page-3. is there any news release, or SP increasing due to only the market showing interest, page-2. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. 38 Biotechnology stocks are valued based on a risk. Latest Posts. Last research or update on this I listened to was by FiftyOneCapital. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. Grabbed my first ever parcel in IXC yesterdy at 80c. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. ASX - By Stock. no point selling now. sentiment based on opinions from HotCopper and others. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. Created with Sketch. ASX - Short Term Trading. See page-34. Created with Sketch. . Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Sentiment for Invex Therapeutics Ltd. . Charts. . Invex Therapeutics Lists on ASXNo worries mate :), page-15. ASX - By Stock. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Invex Granted Type C Meeting with FDA, page-3. Zillow has 23383 homes for sale in British Columbia. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Liked by Jackie Cox-Ziegler, CPHR. IXC Valuation Report MST. Latest Posts. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Learn more. Market open. **Close price adjusted for splits and dividend and/or capital gain distributions. Folks say we are pioneers of craft ice cream in Victoria. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Created with Sketch. Advertise on HotCopper. Join the HotCopper ASX share market. Created with Sketch. . 333334. ASX - By Stock. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. Forums. Here come the vultures. Trading HaltCreated with Sketch. Created with Sketch. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. 0¢ Sentiment: Buy Disclosure: Held. 79 -0. Created with Sketch. is 19. 20. Latest Posts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical.